Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willerson

Showing results (701-710 of 797) with videos related to

Pageof 80
Sort By:
The American Journal of Cardiology|July 30, 2013
Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosisSalim S Virani, Vei-Vei Lee, Ariel Brautbar, et al.
Journal of the American College of Cardiology|July 1, 1989
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study GroupP H Stone, J E Muller, T Hartwell, et al.
The American Journal of Cardiology|October 1, 1987
Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct SizeG H Tofler, P H Stone, J E Muller, et al.
Circulation|March 17, 2004
Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failureReynolds M Delgado, Mohamad A Nawar, Aly M Zewail, et al.
Journal of the American College of Cardiology|June 23, 2001
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary interventionK M Anderson, R M Califf, G W Stone, et al.
American Heart Journal|January 5, 2000
The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trialD Holmes, P Fitzgerald, S Goldberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1977
Comparison of different noninvasive methods of infarct sizing during experimental myocardial infarctionL R Poliner, L M Buja, R W Parkey, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 26, 2017
The ubiquitin-proteasome system: A potential therapeutic target for heart failureYaron D Barac, Fabian Emrich, Efrat Krutzwakd-Josefson, et al.
Circulation Research|February 12, 2019
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated CardiomyopathySirisha M Cheedipudi, Scot J Matkovich, Cristian Coarfa, et al.
Biomaterials|October 24, 2013
The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplastyLesa A Tran, Mayra Hernández-Rivera, Ari N Berlin, et al.
Pageof 80

Showing results (701-710 of 797) with videos related to

Sort By:
Pageof 80
The American Journal of Cardiology|July 30, 2013
Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosisSalim S Virani, Vei-Vei Lee, Ariel Brautbar, et al.
Journal of the American College of Cardiology|July 1, 1989
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study GroupP H Stone, J E Muller, T Hartwell, et al.
The American Journal of Cardiology|October 1, 1987
Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct SizeG H Tofler, P H Stone, J E Muller, et al.
Circulation|March 17, 2004
Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failureReynolds M Delgado, Mohamad A Nawar, Aly M Zewail, et al.
Journal of the American College of Cardiology|June 23, 2001
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary interventionK M Anderson, R M Califf, G W Stone, et al.
American Heart Journal|January 5, 2000
The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trialD Holmes, P Fitzgerald, S Goldberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1977
Comparison of different noninvasive methods of infarct sizing during experimental myocardial infarctionL R Poliner, L M Buja, R W Parkey, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 26, 2017
The ubiquitin-proteasome system: A potential therapeutic target for heart failureYaron D Barac, Fabian Emrich, Efrat Krutzwakd-Josefson, et al.
Circulation Research|February 12, 2019
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated CardiomyopathySirisha M Cheedipudi, Scot J Matkovich, Cristian Coarfa, et al.
Biomaterials|October 24, 2013
The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplastyLesa A Tran, Mayra Hernández-Rivera, Ari N Berlin, et al.
Pageof 80